Curis Lifesciences Limited is a pharmaceutical manufacturing company engaged in the development, production, and distribution of a broad range of pharmaceutical formulations. The company operates through loan license, contract manufacturing, and own-brand marketing models, serving both domestic and international markets.
The company manufactures products such as general pharmaceutical tablets and capsules, oral liquids, external preparations, and sterile ophthalmic ointments. Under its loan license model, Curis manufactures for clients who provide their own raw materials and formulations, while in contract manufacturing, it handles end-to-end production — including procurement of raw materials, formulation, and packaging — for partner brands and merchant exporters.
Curis Lifesciences caters to over 100 corporate clients through loan license and contract manufacturing arrangements and also promotes its own branded products in select international markets including Yemen and Kenya.
The company operates a state-of-the-art manufacturing facility located at Sanand, Gujarat, equipped with advanced machinery and compliant with Good Manufacturing Practices (GMP) to ensure consistent quality, safety, and efficacy of its products.
As of July 31, 2025, Curis Lifesciences Limited employs 95 permanent staff across its operations, reflecting its focus on technical expertise, regulatory compliance, and sustainable business growth.
Curis Lifesciences IPO – Details
| IPO Opening Date | 07 November 2025 |
| IPO Closing Date | 11 November 2025 |
| Issue Type | Bookbuilding IPO |
| Issue Size | Total Issue: 21,50,000 Shares Worth ₹27.52 Crore Fresh Issue: 21,50,000 Shares Worth ₹27.52 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹120 – ₹128 per share |
| Market Lot | 1000 Shares |
| Min Order | 1000 Shares [ 1 Lot ] |
| Listing At | NSE SME |
| Registrar | MUFG Intime India Pvt.Ltd. |
| QIB Shares Offered | 50% |
| NII Shares Offered | 15% |
| Retail Shares Offered | 35% |
Curis Lifesciences IPO – Date Schedule
| IPO Open Date | 07 November 2025 |
| IPO Close Date | 11 November 2025 |
| Basis of Allotment | 12 November 2025 |
| Initiation of Refund | 13 November 2025 |
| Credit of Shares to Demat | 13 November 2025 |
| IPO Listing Date | 14 November 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on November 11, 2025 |
Curis Lifesciences IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹2,56,000 |
| Retail (Max) | 2 | 2,000 | ₹2,56,000 |
| S-HNI (Min) | 3 | 3,000 | ₹3,84,000 |
| S-HNI (Max) | 7 | 7,000 | ₹8,96,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,24,000 |
Competitive Strength
- Experienced Promoters and Management Team.
- Wide range of Products.
- Strategic Location of Manufacturing Facility.
- Scalable Business Model.
- Quality assurance.
Company Promoters
- Mr. Dharmesh Dashrathbhai Patel
- Mr. Siddhant Jayantibhai Pawasia
- Mr. Piyush Gordhanbhai Antala
- Mr. Jaimik Mansukhbhai Patel
Company Financials
| Period | Total Revenue | Total Expense | Profit After Tax | Total Borrowings |
|---|---|---|---|---|
| 31 March 2023 | ₹36.42 Cr | ₹34.23 Cr | ₹1.88 Cr | ₹16.19 Cr |
| 31 March 2024 | ₹35.87 Cr | ₹28.70 Cr | ₹4.87 Cr | ₹17.09 Cr |
| 31 March 2025 | ₹49.65 Cr | ₹41.38 Cr | ₹6.11 Cr | ₹15.62 Cr |
| 31 July 2025 | ₹19.51 Cr | ₹15.79 Cr | ₹2.87 Cr | ₹15.32 Cr |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 55.25% |
| ROCE | 27.83% |
| Debt/Equity | 0.96 |
| RoNW | 37.62% |
| PAT Margin | 12.43% |
| EBITDA Margin | 19.41% |
| Price to Book Value | 12.64 |
| Market Capitalization | 103.48 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 10.29 | 10.66 |
| P/E (x) | 12.44 | 12.01 |
Object Of The Issue
| Objects of the Issue | Expected Amount (in Crore) |
|---|---|
| Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities. | ₹2.44 |
| Capital Expenditure towards Construction of a Storage Facility. | ₹3.62 |
| Pre-payment/Repayment of outstanding Secured Loans. | ₹1.86 |
| Product Registrations in other countries. | ₹2.69 |
| Funding our Working Capital Requirements. | ₹11.25 |
| General Corporate Purposes. | – |
✅Strengths
- Experienced promoters with 13–15 years of pharma industry experience.
- Diverse portfolio of 943 approved products.
- WHO-GMP certified manufacturing facility in Sanand, Gujarat.
- Registered with international regulators in Yemen, Kenya, Philippines, and Nigeria.
- Strong client base of over 100 corporate customers.
⚠️Risks
- High dependency on key clients for revenue.
- Stringent regulatory and quality compliance requirements.
- Fluctuation in raw material prices.
- Intense industry competition.
- Exposure to foreign exchange and export risks.
Curis Lifesciences IPO Promoter Holding
| Pre Issue Share Holding | 92.68% |
| Post Issue Share Holding | 68.03% |
Curis Lifesciences IPO Prospectus
Company Contact Information
| Curis Lifesciences Ltd. PF-23, GIDC Sanand – II, Industrial Estate, Sanand Ahmedabad, Gujarat, 382110 Phone: +91 99045 22543 Email: cs@curisls.com Website: https://curisls.com/ |
Curis Lifesciences IPO Registrar
| MUFG Intime India Pvt.Ltd. Phone: +91-22-4918 6270 Email: curislifesciences.smeipo@in.mpms.mufg.com Website: https://linkintime.co.in/Initial_Offer/public-issues.html |
Curis Lifesciences IPO Lead Manager(s)
| 1. Finaax Capital Advisors Private Limited |
Curis Lifesciences IPO FAQ
| What is Curis Lifesciences IPO? Curis Lifesciences IPO is an SME IPO. The issue is priced at ₹120 – ₹128 per equity share. The IPO is to be listed on NSE SME. |
| When Curis Lifesciences IPO will open? The IPO is to open on 07 November 2025 for QIB, NII, and Retail Investors. |
| What is Curis Lifesciences IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is the Curis Lifesciences IPO Size? Curis Lifesciences IPO size is ₹27.52 Crore. |
| What is Curis Lifesciences IPO Minimum and Maximum Lot Size for Retail? The minimum bid is 2,000 Shares with ₹2,56,000 amount, while the maximum bid is 2,000 Shares with ₹2,56,000. |
| What is the Curis Lifesciences IPO Allotment Date? Curis Lifesciences IPO allotment date is 12 November 2025. |
| What is the Curis Lifesciences IPO Listing Date? Curis Lifesciences IPO listing date is 14 November 2025. The IPO is to be listed on the NSE SME. |
